6-KThe Wire
Alpha Tau Medical Ltd. files 6-K
Filed Jun 23, 2026 · 1mo ago · Accession 0001213900-26-071076
Plain English
Alpha Tau Medical Ltd. announced the successful treatment of the first recurrent glioblastoma patient outside the United States using its Alpha DaRT® technology at Hadassah University Medical Center in Israel. This marks a significant step in the global expansion of their treatment.
Filing details
- Company
- Alpha Tau Medical Ltd.
- Ticker
- DRTS
- CIK
- 1871321
- Form type
- 6-K
- Filing date
- Jun 23, 2026
- Report date
- Jun 23, 2026
- Document
- ea0295467-6k_alpha.htm
- Size
- 35 KB